查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575127

體外診斷契約製造的市場規模、佔有率和趨勢分析報告：按產品、服務、技術、最終用途、地區和細分市場預測，2024-2030 年

In Vitro Diagnostics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Instruments, Software & Services), By Service, By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

體外診斷契約製造市場的成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球體外診斷契約製造市場預計將達到374.5億美元。

預計該市場在預測期內將以 10.04% 的複合年成長率成長。

由於對診斷設備的需求不斷成長、照護現場診斷的普及、分子檢測的進步以及慢性病患病率的增加，預計該市場將出現良好的成長潛力。此外，對具有成本效益的製造、技術創新和診斷方面嚴格監管合規性的需求不斷成長，預計將增加市場收益。因此，醫療保健公司越來越傾向於將製造服務外包給 CMO 和 CDMO，以利用專業知識、簡化生產並縮短上市時間，從而支持醫療保健行業的成長

體外診斷藥物內部製造的高成本是推動市場成長的主要因素。開發和擴大體外診斷的生產需要在基礎設施、專業設備、法規遵循和熟練勞動力方面進行大量資本投資，加速市場成長。這些管理費用會導致資源緊張，並降低中小型組織的盈利和靈活性。因此，透過將製造服務外包給 CMO 或 CDMO，公司可以降低製造成本並利用創新技術，而無需內部資本投資。此外，外包可以加快上市時間、提高擴充性和資源最佳化，進而提高體外診斷市場的競爭力。

此外，持續的技術進步是加速市場需求的主要因素之一，尤其是診斷設備和測試解決方案。分子診斷、次世代定序(NGS) 和自動化等技術創新正在提高體外診斷製造流程的準確性、速度和效率。這些進步正在幫助製造商滿足對個人化醫療、照護現場診斷和更快的疾病檢測方法日益成長的需求。此外，人工智慧主導技術和資料分析的整合最佳化了製造工作流程和品質保證流程，以提高準確性和對監管標準的合規性。此外，許多醫療保健公司正在尋求與契約製造製造商合作，以獲取此類新技術，以加快上市時間、降低營運成本並提高產品的擴充性。因此，服務供應商對先進技術的整合預計將在未來幾年推動市場成長。

報告體外診斷契約製造市場亮點

  • 從產品來看，試劑及耗材細分市場佔據主導地位，2023年銷售佔有率為69.34%。該領域的成長是由於對快速診斷解決方案和個人化醫療的需求不斷成長。此外，對分子診斷和就地檢驗的日益偏好也增加了對專用試劑的需求。此外，自動化和次世代定序(NGS) 的不斷進步進一步增加了對高品質耗材的需求。
  • 依服務業分類，2023年製造業服務業佔最大。對快速、高品質診斷和個人化醫療保健解決方案的需求不斷成長，推動了對擴大生產規模和擴大合約服務市場的需求。此外，對具有成本效益的生產和遵守嚴格監管標準的需求正在推動醫療保健公司將製造外包，以滿足 IVD 市場不斷成長的需求。
  • 按技術分類，免疫測量領域在 2023 年佔據了最大的收益佔有率。這一巨大的收益佔有率歸因於對準確、快速診斷測試的需求不斷成長。此外，慢性病盛行率的增加和對個人化醫療的日益重視預計將推動該行業的成長。此外，生物標記發現的創新和照護現場診斷的擴展正在推動市場擴張。
  • 對先進和可自訂診斷解決方案的需求不斷成長，以及數位技術的整合以提高準確性，是加速該領域成長的關鍵因素。此外，嚴格的品質標準和服務供應商對創新技術的整合正在推動醫療設備製造商與提供創新能力和靈活解決方案的契約製造製造商夥伴關係，以滿足不斷成長的市場需求。
  • 2023 年，北美市場佔據主導地位，佔有率為 41.91%。北美地區慢性病發病率的上升和對先進診斷解決方案的需求正在推動市場擴張。此外，對具有成本效益的製造解決方案的需求不斷成長，正推動醫療保健公司外包體外診斷製造。診斷技術的監管支援和創新正在進一步推動市場勢頭，為受託製造領域的成長和合作創造機會。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 體外診斷契約製造市場的變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術景觀
  • 產業生態系統分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章體外診斷契約製造市場：產品估算與趨勢分析

  • 體外診斷契約製造市場（按產品）：細分儀表板
  • 體外診斷契約製造市場，依產品：波動分析
  • 按產品分類，2018-2030
  • 裝置
  • 試劑/耗材
  • 軟體和服務

第5章體外診斷契約製造市場：服務評估與趨勢分析

  • 體外診斷契約製造市場（按服務）：細分儀表板
  • 體外診斷契約製造市場（按服務）：波動分析
  • 按服務分類，2018-2030
  • 製造服務
  • 檢測開發服務
  • 其他服務

第6章體外診斷契約製造市場：技術評估與趨勢分析

  • 體外診斷契約製造市場（按技術）：細分儀表板
  • 體外診斷契約製造市場（按技術）：波動分析
  • 按技術分類，2018-2030
  • 免疫檢測
  • 臨床化學
  • 分子診斷
  • 血液學
  • 微生物學
  • 凝固
  • 其他

第7章 體外診斷契約製造市場：最終用途估計與趨勢分析

  • 體外診斷契約製造市場，依最終用途：細分儀表板
  • 體外診斷契約製造市場（依最終用途）：波動分析
  • 按最終用途分類，2018-2030
  • 醫療設備公司
  • 學術/研究機構
  • 其他

第8章體外診斷契約製造市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場簡介
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 市場參與企業分類
    • 市場領導者
    • 新興玩家
  • 2023 年企業市場佔有率/估值分析
  • 2023 年服務熱圖分析
  • 公司簡介
    • Jabil Inc.
    • Sanmina Corporation
    • TE Connectivity
    • Celestica Inc.
    • Savyon Diagnostics
    • West Pharmaceutical Services, Inc.
    • Thermo Fisher Scientific
    • KMC Systems
    • Cenogenics Corporation
    • Novo Biomedical
    • Cone Bioproducts
    • Invetech
    • AVIOQ Inc.
    • Meridian Bioscience Inc.
    • Nemera
Product Code: GVR-4-68040-462-6

In Vitro Diagnostics Contract Manufacturing Market Growth & Trends:

The global in vitro diagnostics contract manufacturing market size is expected to reach USD 37.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.04% over the forecast period.

The market is anticipated to witness lucrative growth potential owing to rising demand for diagnostic devices, an upsurge in point-of-care diagnostics, advancements in molecular testing, and the increasing prevalence of chronic diseases. Moreover, the growing need for cost-effective manufacturing, technological innovation, and stringent regulatory compliance for diagnostics is expected to drive the market revenue stream. Thus, the increasing trend for outsourcing manufacturing services to CMOs and CDMOs to access specialized expertise, streamline production, and accelerate time-to-market among healthcare companies is boosting overall market growth.

The high cost of in-house IVD manufacturing is a significant driver propelling the market growth. The need for high capital investment in infrastructure, specialized equipment, regulatory compliance, and skilled workforce to develop and scale up IVD production will accelerate market growth. These overhead costs strain resources, reducing profitability and flexibility among several small and medium-scale organizations. Thus, by outsourcing manufacturing services to CMOs & CDMOs, companies can lower manufacturing costs and gain access to innovative technologies exclusive of the need for internal capital investment. Moreover, outsourcing allows faster market entry, enhanced scalability, and better resource optimization and offers a competitive edge in the IVD market.

Furthermore, continuous technological advancements are among the major factors accelerating the market demand, specifically for diagnostic devices and testing solutions. Innovations such as molecular diagnostics, next-generation sequencing (NGS), and automation have enhanced the accuracy, speed, and efficiency of IVD manufacturing processes. These advancements assist manufacturers to meet the increasing demand for personalized medicine, point-of-care diagnostics, and faster disease detection methods. Moreover, the integration of AI-driven technologies and data analytics optimizes production workflows and quality assurance processes, enhancing precision and compliance with regulatory standards. Furthermore, numerous healthcare companies are involved in collaboration with contract manufacturers to access such novel technologies to accelerate time-to-market, reduce operational costs, and enhance product scalability. Thus, the integration of advanced technologies by service providers is estimated to drive market growth in the forthcoming years.

In Vitro Diagnostics Contract Manufacturing Market Report Highlights:

  • Based on product, the reagents & consumables segment dominated the market with a revenue share of 69.34% in 2023. The segment growth is attributed to increasing demand for rapid diagnostic solutions and personalized medicine. Moreover, increasing preference for molecular diagnostics and point-of-care testing are boosting the need for specialized reagents. In addition, continuous advances in automation and next-generation sequencing (NGS) are further bolstering the demand for high-quality consumables.
  • Based on service, the manufacturing services segment held the largest share in 2023. The increasing demand for rapid, high-quality diagnostics and personalized healthcare solutions spurs the demand for scale-up production, thereby expanding the contract services market. In addition, the need for cost-effective production and compliance with stringent regulatory standards drives healthcare companies to outsource manufacturing to meet the growing needs of the IVD market.
  • Based on technology, the immunoassay segment accounted for the largest revenue share in 2023. This large revenue share is owing to the rising demand for accurate and rapid diagnostic tests. Moreover, the increasing prevalence of chronic diseases and a growing emphasis on personalized medicine is anticipated to drive segmental growth. In addition, innovations in biomarker discovery and the expansion of point-of-care diagnostics are propelling market expansion.
  • Based on end use, the medical device companies segment accounted for the largest revenue share in 2023.Growing demand for advanced, customizable diagnostic solutions and the integration of digital technologies for enhanced accuracy are key factors accelerating segment growth. Moreover, stringent quality standards and the integration of innovative technologies by service providers are major factors accelerating collaboration and partnerships by medical device companies with contract manufacturers that offer innovative capabilities and flexible solutions to meet growing market needs.
  • North America dominated the market with a share of 41.91% in 2023. The increasing prevalence of chronic diseases and the demand for advanced diagnostic solutions in the North American region are propelling market expansion. In addition, the rising need for cost-effective manufacturing solutions is leading healthcare companies to outsource IVD production. Regulatory support and innovation in diagnostic technologies further drive market momentum, creating opportunities for growth and collaboration within the contract manufacturing sector.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. In Vitro Diagnostics Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Industry Ecosystem Analysis
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. In Vitro Diagnostics (Contract Manufacturing Market: Phases Estimates & Trend Analysis

  • 4.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Product: Segment Dashboard
  • 4.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Product: Movement Analysis
  • 4.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 to 2030 (USD Million)
  • 4.5. Reagents & Consumables
    • 4.5.1. Reagents & Consumables Market, 2018 to 2030 (USD Million)
  • 4.6. Software & Services
    • 4.6.1. Software & Services Market, 2018 to 2030 (USD Million)

Chapter 5. In Vitro Diagnostics Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 5.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Service: Segment Dashboard
  • 5.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Service: Movement Analysis
  • 5.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 5.4. Manufacturing Services
    • 5.4.1. Manufacturing Services Market, 2018 to 2030 (USD Million)
  • 5.5. Assay Development Services
    • 5.5.1. Assay Development Services Market, 2018 to 2030 (USD Million)
  • 5.6. Other Services
    • 5.6.1. Other Services Market, 2018 to 2030 (USD Million)

Chapter 6. In Vitro Diagnostics Contract Manufacturing Market: Technology Estimates & Trend Analysis

  • 6.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Technology: Segment Dashboard
  • 6.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Technology: Movement Analysis
  • 6.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Technology, 2018-2030
  • 6.4. Immunoassays
    • 6.4.1. Immunoassays Market, 2018 to 2030 (USD Million)
  • 6.5. Clinical Chemistry
    • 6.5.1. Clinical Chemistry Market, 2018 to 2030 (USD Million)
  • 6.6. Molecular Diagnostics
    • 6.6.1. Molecular Diagnostics Market, 2018 to 2030 (USD Million)
  • 6.7. Hematology
    • 6.7.1. Hematology Market, 2018 to 2030 (USD Million)
  • 6.8. Microbiology
    • 6.8.1. Microbiology Market, 2018 to 2030 (USD Million)
  • 6.9. Coagulation
    • 6.9.1. Coagulation Market, 2018 to 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market, 2018 to 2030 (USD Million)

Chapter 7. In Vitro Diagnostics Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 7.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By End Use: Segment Dashboard
  • 7.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By End Use: Movement Analysis
  • 7.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Medical Device Companies
    • 7.4.1. Medical Device Companies Market, 2018 to 2030 (USD Million)
  • 7.5. Academic & Research Institutions
    • 7.5.1. Academic & Research Institutions Market, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 8. In Vitro Diagnostics Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Thailand
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Australia
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Company Market Share/Assessment Analysis, 2023
  • 9.3. Service Heat Map Analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Jabil Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Service Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Sanmina Corporation
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Service Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. TE Connectivity
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Service Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Celestica Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Savyon Diagnostics
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. West Pharmaceutical Services, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Thermo Fisher Scientific
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. KMC Systems
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Cenogenics Corporation
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Novo Biomedical
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Cone Bioproducts
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Service Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Invetech
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Service Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. AVIOQ Inc.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Service Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Meridian Bioscience Inc.
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Service Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Nemera
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Service Benchmarking
      • 9.4.15.4. Strategic Initiatives

List of Tables

  • Table. 1 Market segmentation
  • Table. 2 Market research process
  • Table. 3 Information procurement
  • Table. 4 Primary research pattern
  • Table. 5 Market research approaches
  • Table. 6 Value chain-based sizing & forecasting
  • Table. 7 QFD modelling for market share assessment
  • Table. 8 Market formulation & validation
  • Table. 9 In Vitro Diagnostics (IVD) contract manufacturing market revenue, 2018 - 2030 (USD Million)
  • Table. 10 In Vitro Diagnostics (IVD) contract manufacturing market snapshot
  • Table. 11 In Vitro Diagnostics (IVD) contract manufacturing market driver impact
  • Table. 12 In Vitro Diagnostics (IVD) contract manufacturing market restraint impact
  • Table. 13 In Vitro Diagnostics (IVD) contract manufacturing sector key takeaways (USD Million)
  • Table. 14 In Vitro Diagnostics (IVD) contract manufacturing Market: Product movement analysis
  • Table. 15 Instruments market, 2018 - 2030 (USD Million)
  • Table. 16 Reagents & consumables market, 2018 - 2030 (USD Million)
  • Table. 17 Software & services market, 2018 - 2030 (USD Million)
  • Table. 18 In Vitro Diagnostics (IVD) contract manufacturing market service key takeaways (USD Million)
  • Table. 19 In Vitro Diagnostics (IVD) contract manufacturing market: service movement analysis
  • Table. 20 Manufacturing services market, 2018 - 2030 (USD Million)
  • Table. 21 Assay development services market, 2018 - 2030 (USD Million)
  • Table. 22 Other services market, 2018 - 2030 (USD Million)
  • Table. 23 In Vitro Diagnostics (IVD) contract manufacturing market technology key takeaways (USD Million)
  • Table. 24 In Vitro Diagnostics (IVD) contract manufacturing market: technology movement analysis
  • Table. 25 Immunoassays market, 2018 - 2030 (USD Million)
  • Table. 26 Clinical chemistry market, 2018 - 2030 (USD Million)
  • Table. 27 Molecular diagnostics market, 2018 - 2030 (USD Million)
  • Table. 28 Hematology market, 2018 - 2030 (USD Million)
  • Table. 29 Microbiology market, 2018 - 2030 (USD Million)
  • Table. 30 Coagulation market, 2018 - 2030 (USD Million)
  • Table. 31 Others market, 2018 - 2030 (USD Million)
  • Table. 32 In Vitro Diagnostics (IVD) contract manufacturing market end use key takeaways (USD Million)
  • Table. 33 In Vitro Diagnostics (IVD) contract manufacturing market: end use movement analysis
  • Table. 34 Medical device companies' market, 2018 - 2030 (USD Million)
  • Table. 35 Academic & research institutions market, 2018 - 2030 (USD Million)
  • Table. 36 Others market, 2018 - 2030 (USD Million)
  • Table. 37 Regional marketplace: Key takeaways
  • Table. 38 Regional outlook, 2023 & 2030
  • Table. 39 North America In Vitro Diagnostics (IVD) contract manufacturing Market, 2018 - 2030 (USD Million)
  • Table. 40 U.S. In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 41 Canada In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 42 Mexico In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 43 Europe In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 44 UK In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 45 Germany In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 46 France In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 47 Italy In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 48 Spain companion animal Health market, 2018 - 2030 (USD Million)
  • Table. 49 Sweden In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 50 Denmark In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 51 Norway In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 52 Asia Pacific In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 53 Japan In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 54 China In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 55 India In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 56 Thailand In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 57 South Korea In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 58 Australia In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 59 Latin America In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 60 Brazil In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 61 Argentina In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 62 Middle East & Africa In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 63 South Africa In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 64 Saudi Arabia In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 65 UAE In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 66 Kuwait In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
  • Table. 67 Market participant categorization

List of Figures

  • Fig. 1 List of Tables
  • Fig. 2 List of Secondary Sources
  • Fig. 3 List of Abbreviations
  • Fig. 4 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 5 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 6 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 7 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 8 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Region, 2018 - 2030 (USD Million)
  • Fig. 9 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 10 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 11 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 12 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 13 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 14 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 18 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 19 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 20 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 21 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 22 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 23 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 24 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 26 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 27 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 28 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 29 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 30 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 31 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 32 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 33 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 34 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 35 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 36 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 37 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 38 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 39 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 40 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 41 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 42 France In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 43 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 44 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 45 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 46 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 47 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 48 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 49 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 50 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 59 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 60 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 61 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 62 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 68 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 69 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 70 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 71 China In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 72 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 73 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 74 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 75 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 76 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 77 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 78 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 79 India In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 83 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 84 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 85 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 86 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 87 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 88 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 89 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 90 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 95 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 96 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 97 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 98 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 100 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 102 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 103 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 104 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 105 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 106 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 107 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 108 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 109 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 110 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 111 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 112 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 113 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 114 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 115 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 116 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 117 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 118 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 119 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 120 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 121 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 122 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 123 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 124 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 125 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)